Meeder Asset Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Meeder Asset Management’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,216	Closed	-$61K	–	2316
2020 Q3	$61K	Hold	11,216	–	–	﹤0.01%	921
2020 Q2	$75K	Hold	11,216	–	–	﹤0.01%	834
2020 Q1	$35K	Buy	11,216 +3,597	+47%	+$19.2K	﹤0.01%	1047
2019 Q4	$54K	Buy	7,619 +1,814	+31%	+$9.68K	﹤0.01%	999
2019 Q3	$22K	Buy	5,805 +4,003	+222%	+$13.6K	﹤0.01%	1285
2019 Q2	$7K	Buy	+1,802	New	+$5.99K	﹤0.01%	1581

Other funds holding RVLP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Meeder Asset Management's RVLP Position: Q4 2020 in Review

Meeder Asset Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2020, closing a stake of 11,216 shares — an estimated $61K sold.

Meeder Asset Management first reported a position in RVLP in Q2 2019 and held it in 6 quarters. The position peaked at $75K in Q2 2020. 60 funds tracked by Wall St. Rank hold RVLP as of Q4 2020.

Meeder Asset Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2020 after selling out during the quarter.
Meeder Asset Management sold 11,216 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2020, an estimated $61K.
Meeder Asset Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2019 and held it in 6 quarters.
Meeder Asset Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $75K in Q2 2020.
60 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2020.

Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.